New cough suppressant medication formula

Research

Throughout the past 30 years, pneumologist Pablo Cortés has researched the mechanisms of coughing, and the potential treatments that can effectively treat it at the root cause.

During his research, he discovered that most cough medications on the market only suppress symptoms instead of treating the originating factors that produce cough. For this reason, he has been developing a formulation that effectively treats the root cause of the cough in humans: the “postnasal drip.”

 

International Patent

New cough suppressant (antitussive) medication formula

Dr. Cortés has patented an antitussive (cough suppressant) medication for children and adults. The formula is a combination of oxymetazoline and ipratropium, medications which are very well known for their practical lack of toxicity, used for anyone from infants to the elderly with very few recorded contraindications. These are safe medications for topical/nasal application.

The medication is administered topically/nasally, effectively reducing nasal secretions that mechanically stimulate the hypopharyngeal and laryngeal receptors responsible for producing cough.

 

This is a great opportunity for investor or companies looking for new markets with innovative products.

The rights to exploit its patent are available for negotiation or licensing. ​

 

Contact us /



Los comentarios están cerrados.